Skip to main content

Carlos Molina Cateriano

Institutions of which they are part

Head of group
Stroke research
Vall Hebron Institut de Recerca

Carlos Molina Cateriano

Institutions of which they are part

Head of group
Stroke research
Vall Hebron Institut de Recerca

Projects

Comprehensive Stroke Center de la Universitat d'Alabama, Birminghan

IP: Carlos Molina Cateriano
Collaborators: Marta Aurora Rubiera Del Fueyo
Funding agency: Instituto de Salud Carlos III
Funding: 6750
Reference: CM07EST/00082
Duration: 15/07/2008 - 28/02/2009

Estrategias para mejorar la eficacia y seguridad del tratamiento con Simvastatina en la Fase Aguda del Ictus Isquémico: STARS trial

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera Del Fueyo, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Olga Maisterra Santos, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Estevo Santamarina Pérez
Funding agency: Instituto de Salud Carlos III
Funding: 175450
Reference: EC07/90195
Duration: 01/11/2007 - 30/06/2012

European Stroke Research Network (EUSTROKE) Grant Agreement Nº 202213

IP: Joan Montaner Villalonga
Collaborators: José Alvarez Sabin, Maria Mar Hernandez Guillamon, Carlos Molina Cateriano, Anna Rosell Novel
Funding agency: EUROPEAN COMMISSION
Funding: 463200
Reference: EUSTROKE_FP7HEALTH2007
Duration: 01/03/2008 - 31/08/2013

RENEVAS - Red de Investigación Cooperativa Neurovascular

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera Del Fueyo, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Instituto de Salud Carlos III
Funding: 793573.69
Reference: RD06/0026/0010
Duration: 02/01/2007 - 31/12/2013

Related news

UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care.

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

Related professionals

Ingrid Galán Cartaña

Ingrid Galán Cartaña

Senior researcher
Clinical Neuroimmunology
Read more
Masotto , Barbara

Masotto , Barbara

Predoctoral researcher
Genetics Medicine
Read more
Mercedes Martinez Mansilla

Mercedes Martinez Mansilla

Research technician
Translational Molecular Pathology
Read more
Ulloa Navas, Ana Daniela

Ulloa Navas, Ana Daniela

Rheumatology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.